Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee Bailey

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedical Instrumentation & Technology|March 31, 2017
Ten Questions With …Renee Bailey
The Lancet. Oncology|December 10, 2003
Getting to grips with gefitinibLisa Renee Bailey, Mette Janas
Current Treatment Options in Cardiovascular Medicine|April 7, 2004
Evolving Treatment Strategies for Carotid Artery StenosisRenee Bailey Van Stavern, Seemant Chaturvedi
Health Promotion International|March 23, 2019
Community health agents, nurses and physicians conducting research in Brazil's family health programRahbel Rahman, Rogério Meireles Pinto, Margareth Santos Zanchetta, et al.
Journal of Child & Adolescent Trauma|September 23, 2024
Deconstructing the Trauma-Altered Identity of Black MenAnnette Bailey, Renee Bailey, Gary Newman, et al.
BJU International|September 8, 2007
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancerEric J Small, Joseph Fontana, Nizar Tannir, et al.
JCO Clinical Cancer Informatics|April 25, 2022
OSPred Tool: A Digital Health Aid for Rapid Predictive Analysis of Correlations Between Early End Points and Overall Survival in Non-Small-Cell Lung Cancer Clinical TrialsKhader Shameer, Youyi Zhang, Andrzej Prokop, et al.
Frontiers in Oncology|August 12, 2021
Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-AnalysisKhader Shameer, Youyi Zhang, Dan Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trialsDaphne W Bell, Thomas J Lynch, Sara M Haserlat, et al.
Journal of Racial and Ethnic Health Disparities|January 22, 2024
Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the PandemicUpton D Allen, Michelle Barton, Julia Upton, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedical Instrumentation & Technology|March 31, 2017
Ten Questions With …Renee Bailey
The Lancet. Oncology|December 10, 2003
Getting to grips with gefitinibLisa Renee Bailey, Mette Janas
Current Treatment Options in Cardiovascular Medicine|April 7, 2004
Evolving Treatment Strategies for Carotid Artery StenosisRenee Bailey Van Stavern, Seemant Chaturvedi
Health Promotion International|March 23, 2019
Community health agents, nurses and physicians conducting research in Brazil's family health programRahbel Rahman, Rogério Meireles Pinto, Margareth Santos Zanchetta, et al.
Journal of Child & Adolescent Trauma|September 23, 2024
Deconstructing the Trauma-Altered Identity of Black MenAnnette Bailey, Renee Bailey, Gary Newman, et al.
BJU International|September 8, 2007
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancerEric J Small, Joseph Fontana, Nizar Tannir, et al.
JCO Clinical Cancer Informatics|April 25, 2022
OSPred Tool: A Digital Health Aid for Rapid Predictive Analysis of Correlations Between Early End Points and Overall Survival in Non-Small-Cell Lung Cancer Clinical TrialsKhader Shameer, Youyi Zhang, Andrzej Prokop, et al.
Frontiers in Oncology|August 12, 2021
Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-AnalysisKhader Shameer, Youyi Zhang, Dan Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trialsDaphne W Bell, Thomas J Lynch, Sara M Haserlat, et al.
Journal of Racial and Ethnic Health Disparities|January 22, 2024
Disproportionate Rates of COVID-19 Among Black Canadian Communities: Lessons from a Cross-Sectional Study in the First Year of the PandemicUpton D Allen, Michelle Barton, Julia Upton, et al.
Pageof 1